Aptose Biosciences Inc
APTO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.36M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.36 Million |
|---|---|
| Enterprise Value | $3.42 Million |
| Earnings per Share | $-10.41 |
| Beta | 1.13 |
| Outstanding Shares | 2,552,429 |
Return
| Return on Equity | -15.99% |
|---|---|
| Return on Assets | 51.69% |
| Return on Invested Capital | -1036.43% |
Valuation & Multiples
| P/E Ratio | -0.65 |
|---|---|
| PEG | 0.65 |
| Price to Sales | - |
| Price to Book Ratio | -0.12 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.64 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 6, 2025
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.98%0% |
|---|---|
| Total Invested | $39,965▲ 11.76% |
| Investors Holding | 40% |
About Aptose Biosciences Inc
CEO: William Rice
